Is neurohormonal activation a major determinant of the response to ACE inhibition in left ventricular dysfunction and heart failure?
- PMID: 7946809
- PMCID: PMC1025598
- DOI: 10.1136/hrt.72.3_suppl.s75
Is neurohormonal activation a major determinant of the response to ACE inhibition in left ventricular dysfunction and heart failure?
Similar articles
-
Which inhibitor of the renin-angiotensin system should be used in chronic heart failure and acute myocardial infarction?Circulation. 2004 Nov 16;110(20):3281-8. doi: 10.1161/01.CIR.0000147274.83071.68. Circulation. 2004. PMID: 15545527 Review. No abstract available.
-
Early neurohormonal effects of trandolapril in patients with left ventricular dysfunction and a recent acute myocardial infarction: a double-blind, randomized, placebo-controlled multicentre study.Eur J Heart Fail. 2001 Jan;3(1):69-78. doi: 10.1016/s1388-9842(00)00137-9. Eur J Heart Fail. 2001. PMID: 11163738 Clinical Trial.
-
Current concepts for the neurohormonal management of left ventricular dysfunction after myocardial infarction.Curr Heart Fail Rep. 2004 Dec;1(4):161-7. doi: 10.1007/s11897-004-0004-9. Curr Heart Fail Rep. 2004. PMID: 16036040 Review.
-
Pathophysiologic role of the renin-angiotensin-aldosterone and sympathetic nervous systems in heart failure.Am J Health Syst Pharm. 2004 May 1;61 Suppl 2:S4-13. doi: 10.1093/ajhp/61.suppl_2.S4. Am J Health Syst Pharm. 2004. PMID: 15160833 Review.
-
ACE inhibitors in heart failure: what more do we need to know?Am J Cardiovasc Drugs. 2005;5(6):351-9. doi: 10.2165/00129784-200505060-00002. Am J Cardiovasc Drugs. 2005. PMID: 16259523 Review.
Cited by
-
Captopril. A review of its pharmacology and therapeutic efficacy after myocardial infarction and in ischaemic heart disease.Drugs Aging. 1995 Sep;7(3):226-53. doi: 10.2165/00002512-199507030-00007. Drugs Aging. 1995. PMID: 8535052 Review.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous